Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |